New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 18, 2013
08:32 EDTROSGRosetta Genomics receives U.S. patent allowance
Rosetta Genomics announces receipt of a Notice of Allowance from the U.S. Patent Office related to U.S. Patent Application No. 12/517,760 entitled "Nucleic Acids Involved in Viral Infection." The allowed claims include a method of reducing the amount of virus replication in a target cell infected with the virus by introducing into the target cell an effective amount of miR-210, its variants or its precursor.
News For ROSG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 8, 2015
07:24 EDTROSGAegis to hold a conference
Subscribe for More Information
September 30, 2015
09:18 EDTROSGRosetta Genomics announces partnership with FNApath
Rosetta Genomics announces that the company has reached an agreement-in-principle with FNApath of Little Rock, Arkansas, under which Rosetta Genomics will provide endocrinologists initially testing their patients for thyroid cancer with the option of using a pathologist or laboratory of their own choosing, or FNApath, a centralized laboratory with an expertise in diagnosing thyroid cancer. In the event of an indeterminate result, the sample would then be tested with RosettaGx Thyroid Reveal, the company's thyroid neoplasia assay for the differential diagnosis of indeterminate fine needle aspirates, or FNAs.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use